A citation-based method for searching scientific literature

Annie Tanenhaus, Timothy Stowe, Andrew Young, John McLaughlin, Rangoli Aeran, I Winnie Lin, Jianmin Li, Raghavendra Hosur, Ming Chen, Jennifer Leedy, Tiffany Chou, Sirika Pillay, Maria Candida Vila, Jennifer A Kearney, Martin Moorhead, Archana Belle, Stephanie Tagliatela. Hum Gene Ther 2022
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


CRISPR/dCas9-based Scn1a gene activation in inhibitory neurons ameliorates epileptic and behavioral phenotypes of Dravet syndrome model mice.
Tetsushi Yamagata, Matthieu Raveau, Kenta Kobayashi, Hiroyuki Miyamoto, Tetsuya Tatsukawa, Ikuo Ogiwara, Shigeyoshi Itohara, Takao K Hensch, Kazuhiro Yamakawa. Neurobiol Dis 2020
37
100

Rescuing AAV gene transfer from neutralizing antibodies with an IgG-degrading enzyme.
Zachary C Elmore, Daniel K Oh, Katherine E Simon, Marco M Fanous, Aravind Asokan. JCI Insight 2020
44
100

In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy.
Christopher E Nelson, Chady H Hakim, David G Ousterout, Pratiksha I Thakore, Eirik A Moreb, Ruth M Castellanos Rivera, Sarina Madhavan, Xiufang Pan, F Ann Ran, Winston X Yan,[...]. Science 2016
719
100

In vivo genome editing improves motor function and extends survival in a mouse model of ALS.
Thomas Gaj, David S Ojala, Freja K Ekman, Leah C Byrne, Prajit Limsirichai, David V Schaffer. Sci Adv 2017
92
100

Mortality in Dravet syndrome: A review.
Sharon Shmuely, Sanjay M Sisodiya, W Boudewijn Gunning, Josemir W Sander, Roland D Thijs. Epilepsy Behav 2016
83
100

Modulating gene regulation to treat genetic disorders.
Navneet Matharu, Nadav Ahituv. Nat Rev Drug Discov 2020
17
100

Progress in gene therapy for neurological disorders.
Michele Simonato, Jean Bennett, Nicholas M Boulis, Maria G Castro, David J Fink, William F Goins, Steven J Gray, Pedro R Lowenstein, Luk H Vandenberghe, Thomas J Wilson,[...]. Nat Rev Neurol 2013
133
100

Incidence of Dravet Syndrome in a US Population.
Yvonne W Wu, Joseph Sullivan, Sharon S McDaniel, Miriam H Meisler, Eileen M Walsh, Sherian Xu Li, Michael W Kuzniewicz. Pediatrics 2015
118
100

Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN.
Kevin D Foust, Xueyong Wang, Vicki L McGovern, Lyndsey Braun, Adam K Bevan, Amanda M Haidet, Thanh T Le, Pablo R Morales, Mark M Rich, Arthur H M Burghes,[...]. Nat Biotechnol 2010
545
100

Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.
Shannon L Maude, Theodore W Laetsch, Jochen Buechner, Susana Rives, Michael Boyer, Henrique Bittencourt, Peter Bader, Michael R Verneris, Heather E Stefanski, Gary D Myers,[...]. N Engl J Med 2018
100

Genome editing with CRISPR-Cas nucleases, base editors, transposases and prime editors.
Andrew V Anzalone, Luke W Koblan, David R Liu. Nat Biotechnol 2020
576
100

Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy.
Diane E Frank, Frederick J Schnell, Cody Akana, Saleh H El-Husayni, Cody A Desjardins, Jennifer Morgan, Jay S Charleston, Valentina Sardone, Joana Domingos, George Dickson,[...]. Neurology 2020
124
100


Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.
Raul D Santos, Frederick J Raal, Alberico L Catapano, Joseph L Witztum, Elisabeth Steinhagen-Thiessen, Sotirios Tsimikas. Arterioscler Thromb Vasc Biol 2015
132
100

A homozygous mutation of voltage-gated sodium channel β(I) gene SCN1B in a patient with Dravet syndrome.
Ikuo Ogiwara, Tojo Nakayama, Tetsushi Yamagata, Hideyuki Ohtani, Emi Mazaki, Shigeru Tsuchiya, Yushi Inoue, Kazuhiro Yamakawa. Epilepsia 2012
60
100

Clades of Adeno-associated viruses are widely disseminated in human tissues.
Guangping Gao, Luk H Vandenberghe, Mauricio R Alvira, You Lu, Roberto Calcedo, Xiangyang Zhou, James M Wilson. J Virol 2004
700
100

Results from a phase 1 study of nusinersen (ISIS-SMN(Rx)) in children with spinal muscular atrophy.
Claudia A Chiriboga, Kathryn J Swoboda, Basil T Darras, Susan T Iannaccone, Jacqueline Montes, Darryl C De Vivo, Daniel A Norris, C Frank Bennett, Kathie M Bishop. Neurology 2016
368
100

A catalog of SCN1A variants.
Christoph Lossin. Brain Dev 2009
148
100


PCDH19-related epilepsy and Dravet Syndrome: Face-off between two early-onset epilepsies with fever sensitivity.
Marina Trivisano, Nicola Pietrafusa, Vincenzo di Ciommo, Simona Cappelletti, Luca de Palma, Alessandra Terracciano, Enrico Bertini, Federico Vigevano, Nicola Specchio. Epilepsy Res 2016
21
100

Antisense oligonucleotides in neurological disorders.
Claudia D Wurster, Albert C Ludolph. Ther Adv Neurol Disord 2018
75
100

Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease.
Davide Di Fusco, Vincenzo Dinallo, Irene Marafini, Michele M Figliuzzi, Barbara Romano, Giovanni Monteleone. Front Pharmacol 2019
40
100

The core Dravet syndrome phenotype.
Charlotte Dravet. Epilepsia 2011
325
100

Altered function of the SCN1A voltage-gated sodium channel leads to gamma-aminobutyric acid-ergic (GABAergic) interneuron abnormalities.
Melinda S Martin, Karoni Dutt, Ligia A Papale, Céline M Dubé, Stacey B Dutton, Georgius de Haan, Anupama Shankar, Sergio Tufik, Miriam H Meisler, Tallie Z Baram,[...]. J Biol Chem 2010
153
100

From focal epilepsy to Dravet syndrome--Heterogeneity of the phenotype due to SCN1A mutations of the p.Arg1596 amino acid residue in the Nav1.1 subunit.
Dorota Hoffman-Zacharska, Elżbieta Szczepanik, Iwona Terczynska, Alicja Goszczanska-Ciuchta, Zofia Zalewska-Miszkurka, Renata Tataj, Jerzy Bal. Neurol Neurochir Pol 2015
8
100

A missense mutation in SCN1A in brothers with severe myoclonic epilepsy in infancy (SMEI) inherited from a father with febrile seizures.
Kazue Kimura, Takashi Sugawara, Emi Mazaki-Miyazaki, Kyoko Hoshino, Yoshiko Nomura, Akihiko Tateno, Kei Hachimori, Kazuhiro Yamakawa, Masaya Segawa. Brain Dev 2005
39
100

The spectrum of SCN1A-related infantile epileptic encephalopathies.
Louise A Harkin, Jacinta M McMahon, Xenia Iona, Leanne Dibbens, James T Pelekanos, Sameer M Zuberi, Lynette G Sadleir, Eva Andermann, Deepak Gill, Kevin Farrell,[...]. Brain 2007
358
100

Lentiviral vectors can be used for full-length dystrophin gene therapy.
John R Counsell, Zeinab Asgarian, Jinhong Meng, Veronica Ferrer, Conrad A Vink, Steven J Howe, Simon N Waddington, Adrian J Thrasher, Francesco Muntoni, Jennifer E Morgan,[...]. Sci Rep 2017
24
100

Adenovirus-Mediated Gene Delivery: Potential Applications for Gene and Cell-Based Therapies in the New Era of Personalized Medicine.
Cody S Lee, Elliot S Bishop, Ruyi Zhang, Xinyi Yu, Evan M Farina, Shujuan Yan, Chen Zhao, Zongyue Zheng, Yi Shu, Xingye Wu,[...]. Genes Dis 2017
270
100

Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations.
Lucia Mora-Jimenez, Miguel Valencia, Rocio Sanchez-Carpintero, Jan Tønnesen, Saja Fadila, Moran Rubinstein, Manuela Gonzalez-Aparicio, Maria Bunuales, Eva Fernandez-Pierola, Maria Jesus Nicolas,[...]. Mol Ther Nucleic Acids 2021
2
100



De novo loss-of-function mutations in CHD2 cause a fever-sensitive myoclonic epileptic encephalopathy sharing features with Dravet syndrome.
Arvid Suls, Johanna A Jaehn, Angela Kecskés, Yvonne Weber, Sarah Weckhuysen, Dana C Craiu, Aleksandra Siekierska, Tania Djémié, Tatiana Afrikanova, Padhraig Gormley,[...]. Am J Hum Genet 2013
132
100


Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy.
Eugenio Mercuri, Basil T Darras, Claudia A Chiriboga, John W Day, Craig Campbell, Anne M Connolly, Susan T Iannaccone, Janbernd Kirschner, Nancy L Kuntz, Kayoko Saito,[...]. N Engl J Med 2018
656
100

Nusinersen in later-onset spinal muscular atrophy: Long-term results from the phase 1/2 studies.
Basil T Darras, Claudia A Chiriboga, Susan T Iannaccone, Kathryn J Swoboda, Jacqueline Montes, Laurence Mignon, Shuting Xia, C Frank Bennett, Kathie M Bishop, Jeremy M Shefner,[...]. Neurology 2019
129
100

[Phase III randomized clinical trial of intratumoral injection of E1B gene-deleted adenovirus (H101) combined with cisplatin-based chemotherapy in treating squamous cell cancer of head and neck or esophagus].
Zhong-Jun Xia, Jian-Hua Chang, Li Zhang, Wen-Qi Jiang, Zhong-Zhen Guan, Ji-Wei Liu, Yang Zhang, Xiao-Hua Hu, Guo-Hua Wu, Hua-Qing Wang,[...]. Ai Zheng 2004
142
100

Genome Editing for CNS Disorders.
Fábio Duarte, Nicole Déglon. Front Neurosci 2020
11
100


Mapping genetic modifiers of survival in a mouse model of Dravet syndrome.
A R Miller, N A Hawkins, C E McCollom, J A Kearney. Genes Brain Behav 2014
91
100

Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs.
Jie Jiang, Qiang Zhu, Tania F Gendron, Shahram Saberi, Melissa McAlonis-Downes, Amanda Seelman, Jennifer E Stauffer, Paymaan Jafar-Nejad, Kevin Drenner, Derek Schulte,[...]. Neuron 2016
320
100

Introduction to viral vectors.
James N Warnock, Claire Daigre, Mohamed Al-Rubeai. Methods Mol Biol 2011
66
100

Influence of Pre-existing Anti-capsid Neutralizing and Binding Antibodies on AAV Vector Transduction.
Zachary Fitzpatrick, Christian Leborgne, Elena Barbon, Elisa Masat, Giuseppe Ronzitti, Laetitia van Wittenberghe, Alban Vignaud, Fanny Collaud, Séverine Charles, Marcelo Simon Sola,[...]. Mol Ther Methods Clin Dev 2018
89
100

De novo mutations in HCN1 cause early infantile epileptic encephalopathy.
Caroline Nava, Carine Dalle, Agnès Rastetter, Pasquale Striano, Carolien G F de Kovel, Rima Nabbout, Claude Cancès, Dorothée Ville, Eva H Brilstra, Giuseppe Gobbi,[...]. Nat Genet 2014
137
100


Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.
Hao Yin, Wen Xue, Sidi Chen, Roman L Bogorad, Eric Benedetti, Markus Grompe, Victor Koteliansky, Phillip A Sharp, Tyler Jacks, Daniel G Anderson. Nat Biotechnol 2014
612
100

Molecular Mechanisms of Antisense Oligonucleotides.
Stanley T Crooke. Nucleic Acid Ther 2017
165
100

dCas9-Based Scn1a Gene Activation Restores Inhibitory Interneuron Excitability and Attenuates Seizures in Dravet Syndrome Mice.
Gaia Colasante, Gabriele Lignani, Simone Brusco, Claudia Di Berardino, Jenna Carpenter, Serena Giannelli, Nicholas Valassina, Simone Bido, Raffaele Ricci, Valerio Castoldi,[...]. Mol Ther 2020
81
100

Non viral vectors in gene therapy- an overview.
Murali Ramamoorth, Aparna Narvekar. J Clin Diagn Res 2015
356
100

Specific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome.
Christine S Cheah, Frank H Yu, Ruth E Westenbroek, Franck K Kalume, John C Oakley, Gregory B Potter, John L Rubenstein, William A Catterall. Proc Natl Acad Sci U S A 2012
187
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.